Sara Bashyam
Adult Health · Winter Park, FLNPI 1639583909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 6.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,451, 5.8 times the $424 reported in 2021. Among adult health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $106.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$372
- AstraZeneca$370
- Neurocrine Biosciences, Inc.$359
- Novo Nordisk$343
- Medtronic$314
- Gilead$259
- plus $4K from 26 others
Across 1 payment — averaging $11,467 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Integra Lifesciences Corporation$11K
What the payments were for
- Food & beverage$5,662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 3 | $372 |
| AstraZeneca | 3 | $370 |
| Neurocrine Biosciences, Inc. | 3 | $359 |
| Novo Nordisk | 3 | $343 |
| Medtronic | 4 | $314 |
| Gilead | 2 | $259 |
| Grifols USA, LLC | 2 | $252 |
| Teva Pharmaceuticals USA, Inc. | 2 | $231 |
| Abiomed | 2 | $229 |
| Johnson & Johnson | 2 | $220 |
| Amgen | 2 | $218 |
| Sanofi | 2 | $191 |
| Boston Scientific | 2 | $171 |
| Edwards Lifesciences | 2 | $171 |
| Baxter Healthcare | 1 | $146 |
| Nuwellis, Inc. | 1 | $143 |
| Shield Therapeutics Inc | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Sobi, Inc | 1 | $120 |
| Idorsia Pharmaceuticals US Inc | 1 | $119 |
| Atricure, Inc. | 1 | $117 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $116 |
| Biogen | 1 | $107 |
| Novartis | 1 | $106 |
| Genentech USA, Inc. | 1 | $102 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Merck | 1 | $95 |
| Boehringer Ingelheim | 1 | $91 |
| GRT US Holding, Inc. | 1 | $89 |
| Abbott | 2 | $79 |
| Bayer | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$372
- INGREZZA$359
- BREZTRI$256
- Prolastin-C Liquid$252
- XARELTO$220
- Repatha$218
- WATCHMAN Access System$147
- SYMPLICITY G3$146
- STARLING SYSTEM$146
- AQUADEX SMARTFLOW CONSOLE$143
- Austedo XR$131
- Livdelzi$130
- Epclusa$130
- ACCRUFER$125
- FABRAZYME$122
- UPTRAVI$122
- OPSUMIT$122
- Gamifant$120
- Wegovy$120
- QUVIVIQ$119
How this compares
$5,662 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Winter Park
- Ashley PontenbergWinter Park$136K
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.